🔗 Share this article

An underground market for unapproved slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and assertions of next-day UK delivery. Sellers promote the substance there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Professionals Voice Worries

However, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Some experts stated the demand for retatrutide could be connected to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.

Several influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, risking fines, prosecution or prison.

Platform Reaction and Content Removal

According to TikTok, the service has removed problematic content and prohibited associated hashtags and search suggestions. The company said it was committed to keeping the platform safe and investing in enhancing compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to nine thousand members selling retatrutide using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, populated with photos of slimming results, positive reviews and detailed guides for mixing or injecting at home.

After minutes of entering one group, a vendor shared contact information, where the majority of purchases take place. The seller provided an guidebook and guaranteed delivery within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about weight, medical conditions or past usage.

Product Information and Pricing

Within these communities, posts display dark colored packages with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how long a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for Telegram stated it actively monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they cannot confirm. Although the research behind this drug is valid, these digital products may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.

Her staff has previously encountered patients harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to potentially significant medical dangers”.